A community jury on PSA screening: What do well-informed men want the government to do about prostate cancer screening - A qualitative analysis

BMJ Open

Volumn 4, Issue 4, 2014, Pages

  Rychetnik, Lucie ^a,b   Doust, Jenny ^c   Thomas, Rae ^c   Gardiner, Robert ^d,e   MacKenzie, Geraldine ^c   Glasziou, Paul ^c  

^a UNIVERSITY OF NOTRE DAME   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BOND UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COURT; GENERAL PRACTITIONER; GOVERNMENT; HEALTH CARE QUALITY; HUMAN; INTERNET; MALE; MEDICAL DECISION MAKING; PROSTATE CANCER; QUALITATIVE ANALYSIS; ATTITUDE TO HEALTH; BLOOD; CONTROLLED STUDY; EARLY CANCER DIAGNOSIS; HEALTH CARE POLICY; MASS SCREENING; MIDDLE AGED; PROCEDURES; PROSTATIC NEOPLASMS; PUBLIC OPINION; QUEENSLAND; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

AGED; ATTITUDE TO HEALTH; EARLY DETECTION OF CANCER; GOVERNMENT PROGRAMS; HEALTH POLICY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PUBLIC OPINION; QUEENSLAND; RISK ASSESSMENT;

EID: 84899748066     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004682     Document Type: Article

References (33)

1. Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155:762-71.
2. Djulbegovic M, Beyth RJ, Neuberger MM, et al. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ 2010;341:c4543.
3. Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer. Cochrane Database Syst Rev 2013;1:CD004720.
4. Andriole GL, Crawford ED, Grubb RL 3rd, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104:125-32.
5. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med 2012;366:981-90.
6. Mackie A; UK National Screening Committee. Screening for prostate cancer review against programme appraisal criteria for the UK National Screening Committee (UK NSC). London: National Health Service, 2010.
7. Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2012;157:120-34.
8. American Urological Association. Early detection of prostate cancer: AUA guideline. 2013; (7 Jun 2013). http://www.auanet.org/education/guidelines/ prostate-cancer-detection.cfm
9. Mitka M. Group now advises against routine PSA screening. JAMA 2013;309:2316.
10. The Melbourne Consensus Statement on Prostate Cancer Testing. A consensus view on the early detection of prostate cancer, led by experts at the Prostate Cancer World Congress, Melbourne, 7-10 August 2013. http://www. prostatecancerresearch.org.au/new-apcr/wp-content/uploads/The-Melbourne- Consensus-Statement-on-PSA-Testing.pdf
11. Entwistle VA, Carter SM, Trevena L, et al. Communicating about screening. BMJ 2008;337:3.
12. Irwig L, Glasziou P. Informed consent for screening by community sampling. Effect Clin Pract 2000;3:47-50.
13. Stefanek ME. Uninformed compliance or informed choice? A needed shift in our approach to cancer screening. J Natl Cancer Inst 2011;103:1821-6.
14. Shaw D, Elger B. Evidence-based persuasion: an ethical imperative. JAMA 2013;309:1689 -90.
15. Woolf SH, Krist A. The liability of giving patients a choice: shared decision making and prostate cancer. Am Fam Physician 2005;71:1871-2. (Pubitemid 40695952)
16. Levinson W, Kao A, Kuby A, et al. Not all patients want to participate in decision making-a national study of public preferences. J Gen Intern Med 2005;20:531-5. (Pubitemid 41003809)
17. Rychetnik L, Carter SM, Abelson J, et al. Enhancing citizen engagement in cancer screening through deliberative democracy. J Natl Cancer Inst 2013;105:380-6.
18. Hawkes N. Women 'jurors' are asked how to present risk-benefit ratio of breast cancer screening. BMJ (Clin Res Ed) 2012;345:e7886.
19. Paul C, Nicholls R, Priest P, et al. Making policy decisions about population screening for breast cancer: the role of citizens' deliberation. Health Policy 2008;85:314-20. (Pubitemid 351179536)
20. Goodin RE, Dryzek JS. Deliberative impacts: the macro-political uptake of mini-publics. Politics Soc 2006;34:219-44. (Pubitemid 43742315)
21. Andrology Australia. Factsheet: PSA testing. Victoria, Australia: Monash Institute of Medical Research, 2013. https://www.andrologyaustralia.org/wp- content/uploads/Factsheet-PSA-Test.pdf
22. Cancer Council Australia. Early detection factsheets: prostate cancer. 2013. http://www.cancer.org.au/about-cancer/early-detection/early-detection- factsheets/prostate-cancer.html
23. Ilic D, Neuberger MM, Djulbegovic M, et al. Screening for prostate cancer (Review-Plain Language Summary). Cochrane Database Syst Rev 2013;1:CD004720.
24. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice (The Red Book) Chapter 98 (Prostate Cancer). 8th edn. South Melbourne, Victoria: The Royal Australian College of General Practitioners, 2012.
25. Urological Society of Australia and New Zealand. PSATesting Policy (executive summary). 2009. http://www.usanz.org.au/uploads/29168/ufiles/USANZ- 2009-PSA-Testing-Policy-Final1.pdf
26. Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London: SAGE Publications, 2006.
27. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ 2001;323:1123 -4.
28. Movember Australia. About Movember. http://aumovembercom/about/ (accessed 30 Jul 2013).
29. Elwood P, Longley M. My health: whose responsibility? A jury decides. J Epidemiol Community Health 2010;64:761-4.
30. Currow D, Armstrong B. PSA needs order MJA insight 2011; (25 May 2012). http://www.mjainsight.com.au/view?post=david-currow-bruce-armstrong-psa-needs- order&post-id=6489&cat=comment
31. Prasad SM, Drazer MW, Huo D, et al. 2008 US preventive services task force recommendations and prostate cancer screening rates. JAMA 2012;307:1692 -4.
32. Agency for Healthcare Research and Quality. The AHRQ community forum deliberative methods demonstration effective health care program. 2013. http://www.effectivehealthcare.ahrq.gov/ehc/assets/File/Demonstration-Methods- Deliberative-130213.pdf
33. NHMRC. Public consultation on the draft Prostate Specific Antigen (PSA) testing for prostate cancer in asymptomatic men: information for health practitioners. 2013. http://consultations.nhmrc.gov.au/public-consultations/ prostate-cancer (accessed 31 Jul 2013).